# Nuclide record fap-2286 (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/fap-2286/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "fap-2286" ;
  schema:name "FAP-2286 (177Lu / 68Ga)"@en ;
  schema:description "A FAP-targeted theranostic pair: one version images almost any solid tumour, the other treats it with radiation."@en ;
  schema:url <https://nuclide.cc/drugs/fap-2286/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=FAP-2286> ;
  nuclide:status "phase-2" ;
  nuclide:modality "Theranostic pair (peptide radioligand)" ;
  nuclide:related <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:technologies <https://nuclide.cc/technologies/fapi-pet/>, <https://nuclide.cc/technologies/radioligand-therapy/> ;
  nuclide:targets <https://nuclide.cc/targets/fap/> ;
  nuclide:companies <https://nuclide.cc/companies/novartis/> ;
  nuclide:trials <https://nuclide.cc/trials/nct05939414/>, <https://nuclide.cc/trials/nct06520345/>, <https://nuclide.cc/trials/nct07219238/>, <https://nuclide.cc/trials/nct05413850/>, <https://nuclide.cc/trials/nct06894511/>, <https://nuclide.cc/trials/nct05142696/>, <https://nuclide.cc/trials/nct04939610/> .